Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

Detalles Bibliográficos
Autores principales: Haratani, Koji, Hayashi, Hidetoshi, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171785/
https://www.ncbi.nlm.nih.gov/pubmed/32312270
http://dx.doi.org/10.1186/s12916-020-01583-0
_version_ 1783524135430782976
author Haratani, Koji
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
author_facet Haratani, Koji
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
author_sort Haratani, Koji
collection PubMed
description
format Online
Article
Text
id pubmed-7171785
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71717852020-04-24 Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary? Haratani, Koji Hayashi, Hidetoshi Nakagawa, Kazuhiko BMC Med Commentary BioMed Central 2020-04-21 /pmc/articles/PMC7171785/ /pubmed/32312270 http://dx.doi.org/10.1186/s12916-020-01583-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Haratani, Koji
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title_full Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title_fullStr Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title_full_unstemmed Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title_short Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
title_sort association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171785/
https://www.ncbi.nlm.nih.gov/pubmed/32312270
http://dx.doi.org/10.1186/s12916-020-01583-0
work_keys_str_mv AT haratanikoji associationofimmunerelatedadverseeventswithimmunecheckpointinhibitorefficacyrealorimaginary
AT hayashihidetoshi associationofimmunerelatedadverseeventswithimmunecheckpointinhibitorefficacyrealorimaginary
AT nakagawakazuhiko associationofimmunerelatedadverseeventswithimmunecheckpointinhibitorefficacyrealorimaginary

Ejemplares similares